In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Off-label combination of leadless pacemakers and subcutaneous defibrillators in bilateral venous occlusion: a new reimplantation strategy after lead extraction.

Session Device Therapy ePosters

Speaker Andrea Di Cori

Event : ESC Congress 2020

  • Topic : arrhythmias and device therapy
  • Sub-topic : Device Complications and Lead Extraction
  • Session type : ePosters

Authors : A Di Cori (Pisa,IT), S Viani (Pisa,IT), S Tolve (Pisa,IT), G Zucchelli (Pisa,IT), V Barletta (Pisa,IT), M Giannotti Santoro (Pisa,IT), M Parollo (Pisa,IT), T Cellamaro (Pisa,IT), G Branchitta (Pisa,IT), M Carluccio (Pisa,IT), L Segreti (Pisa,IT), L Paperini (Pisa,IT), R De Lucia (Pisa,IT), E Soldati (Pisa,IT), MG Bongiorni (Pisa,IT)

A Di Cori1 , S Viani1 , S Tolve1 , G Zucchelli1 , V Barletta1 , M Giannotti Santoro1 , M Parollo1 , T Cellamaro1 , G Branchitta1 , M Carluccio1 , L Segreti1 , L Paperini1 , R De Lucia1 , E Soldati1 , MG Bongiorni1 , 1Santa Chiara Hospital, Department of Cardiovascular Diseases - Pisa - Italy ,

Device Complications and Lead Extraction

Background: Subcutaneous implantable cardioverter-defibrillator (S-ICD) and leadless pacemakers (LPM) provide an alternative to transvenous implantable devices. Sometimes, after transvenous (TV) lead extraction, patients show a bilateral venous occlusion, resulting not eligible for TV reimplantation.

Purpose: This analysis was designed to provide preliminary data on feasibility and short-term outcome of an hybrid combination (Hyb) of s-ICD plus LPM  after TV-ICD explantation, in patients without anatomical transvenous reimplantation options.

Methods: Among 2684 consecutive extracted patients, 31 (1.1%) were reimplanted with a LPM, 66 (2.4%) with a s-ICD and 6 (0.2%) patients with an Hyb combination. Hyb strategy was considered in patients with a pacing plus defibrillating indication, and an anatomical barrier, as bilateral superior venous occlusion or massive bilateral skin erosion.

Results: Hyb patients were old (72 ±10 years), with a prevalent ischemic disease (4/6) and a reduced ejection fraction (43±16%). Extraction indication was infection in 4 and severe venous occlusion in 2, and included 2 single chamber, 2 dual chamber and 2 biventricular ICD. After extraction, reimplantation timing was 7±6 days, LPM was implanted before and sICD the day after.

LPM reimplantation indication was sinus node dysfunction in 2 and AV block in 4. Implantation duration was 68±23 and fluoroscopy time 9.4±2.3 min. ICD reimplantation indication was primary prevention in 4 and secondary prevention in 2. Implantation duration was 118±10 min. No complications were observed. At 1 year, no complications were observed, including device related cross-talks.

Conclusions: The Hyb strategy is a potential option after TV-ICD explantation in pacemaker dependent patients, when transvenous implantation is not available.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are